US May Provide COVID-19 Vaccine To Other Nations If Ready: Trump

US May Provide COVID-19 Vaccine To Other Nations If Ready: Trump || NeoDrafts

  • Author : Victor
  • Published : August 03, 2020

US May Provide COVID-19 Vaccine To Other Nations If Ready: Trump

U.S. President Donald Trump has announced that his country may, when ready, deliver a novel coronavirus vaccine to other countries. The American leader previously raised the likelihood of a vaccine by the end of 2020. Speaking at a press conference on July 28, Trump said that when they have a vaccine, it would be released and taken care of.

Speaking of disseminating it to other countries, he said, “It’s going to be a rapid process all over the world. Talking further, he said, “maybe we’re going to bring a lot of vaccines to other parts of the world as we do with ventilators and other stuff that we’ve all suddenly become good at producing.”

Trump and Vice President Mike Pence toured vaccine testing sites on Monday, marking the launch of the most prominent vaccine study trial yet. Their visits to North Carolina and Florida, when the White House has been dealing with the most famous virus event since the outbreak started and a significant rise in the virus.

Under the Operation High-Speed vaccine system of the federal government, several COVID-19 vaccines are being produced simultaneously with the target of providing 300 million secure and reliable doses by January 2021.

Trump toured the FUJIFILM Diosynth Biotechnology Innovation Center in Morrisville, a suburb of Raleigh. The plant has started the development of the first batch of potential vaccine produced by Novavax, a company in Maryland.

The batches developed at the North Carolina facility will be used for a Phase 3 clinical trial of up to 30,000 participants, scheduled to begin this autumn, to assess the safety and efficacy of the medication, according to Novavax, which earned $1.6 billion from the federal government under Operation Warp Pace.

Trump’s plan plans to make the vaccine accessible by the end of the year or the beginning of 2021.

On Monday, the National Institutes of Health (NIH) announced that US scientists had started a phase three trial of the new vaccine built by the biotechnology company Moderna. The NIH plans to perform a study at several U.S. clinical testing sites with the involvement of approximately 30,000 volunteers that are not diagnosed with the novel coronavirus.

The President is keen to highlight the success of vaccine production before the electorate head to the polls in maybe three months. Dr Anthony Fauci, the nation’s leading infectious diseases expert, said he was cautiously hopeful that one and perhaps more vaccines would be ready by the end of this year.

Trump sat inside the Lincoln Memorial and answered questions from two Fox reporters, as well as from people who posed questions about Fox’s social media sites. Trump responded to a Nebraska man who healed from COVID-19 by saying, “We think we’re going to have a vaccine by the turn of this year.” He also said that his administration was pushing hard for Remdesivir. U.S. public health authorities said the vaccine is potentially 18 months away. But at the end of April, Dr. Anthony Fauci said that it is possible that if a vaccine is created soon, it may be widely distributed as early as January.

For more information, kindly visit our official website –

Share this:

Connect with Us

Recent Post


You may also like :

Leave a Reply

Your email address will not be published. Required fields are marked *